Elanie.zh
Lv0
0 积分
2021-12-31 加入
-
Ribociclib plus Endocrine Therapy in Early Breast Cancer
5个月前
已完结
-
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
5个月前
已完结
-
原发性中枢神经系统淋巴瘤诊断及治疗专家共识(2024年版)
5个月前
已完结
-
前列腺癌药物去势治疗随访管理中国专家共识(2024版)
5个月前
已完结
-
《中国实用妇科与产科杂志》
5个月前
已完结
-
FDA-approved small-molecule kinase inhibitors
5个月前
已完结
-
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
6个月前
已完结
-
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
6个月前
已完结
-
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
6个月前
已完结
-
Mechanisms of type-I- and type-II-interferon-mediated signalling
6个月前
已完结